Company intelligence / Profile preview

InnoAngel Fund

Beijing, China

Ownership: Private
Employees: ~50
Development stage: Other

Overview

InnoAngel Fund is a venture capital firm that invests in early-stage companies (seed to pre-Series A) across various sectors including artificial intelligence, robotics, consumer products, entertainment, information technology, healthcare, and financial technology. The fund has a notable focus on healthcare-related startups, investing in technologies such as RNA-targeting small molecule therapeutics, delivery carrier technology, chemical synthesis, synthetic biology, and gene therapy.

Modalities: Small MoleculeGene Therapy
Industry: Investors

Beyond the preview

Go deeper on InnoAngel Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoAngel Fund.

Explore the full profile